PharmaCyte Biotech (PMCB) Inventory (2011 - 2012)
PharmaCyte Biotech (PMCB) posted quarterly Inventory of $9620.0 for Q3 2012, up 26.3% year-over-year from $7617.0 in Q3 2011, and up 40.52% quarter-over-quarter from $6846.0 in Q2 2012.
PharmaCyte Biotech (PMCB) Inventory (2011 - 2012) Analysis & Trends
PharmaCyte Biotech (PMCB) has reported Inventory for 2 consecutive years, with $9620.0 the latest figure, recorded in Q3 2012.
- In Q3 2012, Inventory rose 26.3% year-over-year to $9620.0; the TTM figure through Jul 2012 stood at $9620.0 (up 26.3% YoY), while the FY2012 annual figure was $6846.0, down 63.4% from the prior year.
- Inventory advanced to $9620.0 in Q3 2012 per PMCB's latest filing, from $6846.0 in the prior quarter.
- Across five years, Inventory topped out at $18706.0 in Q2 2011 and bottomed at $2307.0 in Q1 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 280.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 732.60 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 97.11 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 128.86 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 142.38 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | PharmaCyte Biotech | 4.38 Mn | 4.38 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2012 | 9,620.00 |
| Apr 30, 2012 | 6,846.00 |
| Jan 31, 2012 | 2,307.00 |
| Oct 31, 2011 | 4,518.00 |
| Jul 31, 2011 | 7,617.00 |
| Apr 30, 2011 | 18,706.00 |